MDAI Spectral AI Inc

$MDAI A clear account of what has been completed, delayed, changed or discontinued would allow shareholders to assess the company’s current position without relying on incomplete or disconnected announcements. I'll expand separetely but I am referring to: Commercial revenue timeline, DeepView for diabetic foot ulcers, Wound measurement, Four DeepView platforms, Strategic and commercial relationships, Formation and financing of Spectral IP and the proposed spin-off, public offering, shareholder distribution of Spectral IP. The public information shows that Spectral AI has achieved important regulatory, technical and government-funding milestones; including UKCA authorisation for the burn indication, FDA De Novo classification for the DeepView System for burns and continued BARDA support. However, the same public record also shows that some commercial and corporate objectives moved beyond their initial timetables or developed differently from the route first announced.

$MDAI Spectral seems to be unable to attract investment interest at this point. Becoming a tough situation 4 months after approval, zero public announcements on any placements, and no information on price point for revenue generation with the approval. I can’t disclose any specific discussion from last week but nothing that’s not already publically available info. There’s a LOT of unanswered questions about current company direction. Unless we get a pleasant surprise of a buyout, not much else going on here is acceptable

$MDAI I am glad they clairifed the $2750 in patient fee which was on the one of the slides of the presentation. This is extra money and I bet it gets approved so this is great news and 2027 is looking good. Patience is the key because AI small cap stocks have been getting hammered all of 2026 and a big reversal is coming so get ready to ride the wave.

$MDAI YTD chart says up 12%. Full yr of accomplishments with sales expected in the 4th qtr - which starts next week. I like Mr Capone's direction for the company. Patience longs.

$MDAI Amazing news. Approval for NTAP almost means guaranteed sales as far as I can see. Only thing is it takes a year to be approved so wonder what they'll be doing in the meantime?

$MDAI The presentation reveals the reimburesment to hospitals is not done so november approval has to come before sales can commence. No hospital will buy a device until it can calculate what it is going to charge for it. Expect sales announcement 1st of december with delivery in early 2027. The approval of the handheld miltary device should also be revealed about that time frame. 2 more months of pain and then joy.

$MDAI NT-APC 1523 is (Outpatient) Separate payment per scan ($2,750) willl likely be confirmed 1st Nov 2026 following 1st Sept announcement. NTAP (Inpatient) funding Nov 2027. Outpatient is the MOST important as it supports the ARDA rollout revenues through 2027. All these announcements are part of the strategic roll out. MORE GOOD NEWS TO COME 😜😜👍

$MDAI Bounced off 50ema on the daily and closed in line with top bollinger. MACD in bullish separation on the daily and may cross 0 line tomorrow. MACD pinching on weekly chart and may cross next week. CMF over the past months has made sets of higher lows while price has dropped. CCI is in a bullish zone over 100 where large price moves possible. Stochisstics in bullish separation on daily and weekly. RSI squarely in the middle on daily and weekly chart indicating plenty of room to run. Best setup in a while here.

$MDAI intraday time frames looking quite strong in terms of stochisstics, moving average crosses, A/D, and ADX. Hit our head on the 50ema on the daily. If we pop that with some force maybe we get some follow through on the weekly to the 200ema (around 4).

$MDAI risk appetite for tech coming back into the market. ROIC could be quite darn high here once revs flow.

$MDAI Interesting… 105,000 shares (half the day’s volume) traded in the last 15 minutes. Pushing the price up to close near the high of the day.👍🏼

$MDAI I’m sure some of you here have been an unfortunate witness to my back and forth with this… let’s go with “character “ over the last weeks. I have no idea what his intent is, but I can say with certainty that he is completely fraudulent and has time and time again failed to substantiate anything he has ever tried to insult me or challenge me with. I would recommend ignoring any posts from this account lest ye fall victim to the endless rabbit hole of nonsense that I did. If anyone has any questions regarding MDAI, you’re welcome to reach out. I was there in NY. Cheers.

$MDAI I have a feeling it breaks $2 end of the month to start a rally to like 4.50 on anticipation of commercial revenue. (then will probably tank when we find out that means only one install, but thats later)

$MDAI Next week is the H. C. Wainwright Global Conference. What should expect from this event? Could this be the beginning of enticing major investors to buy this stock, or an opportunity to explore selling the company? Thoughts anyone?

$MDAI - added today- seems plain as day to me how this may go but potential share price target on the is like impossible to get grip on - has much to do with potential top line and pressers in the ER and with pharma names In pressers to get that extra pump from retail - in it to win though- good luck

$MDAI You bailed too early “Dickie”, things about about to heat up here in the next few months!🚀 The announcement of commercial sales by the end of the year, is the catalyst we’ve been waiting for.

$MDAI hopefully no more dilution planned. 2.2M short shares betting on dilution. That's the only way they can cover without running the price.

$MDAI other than a brief run to $3 on FDA news, this has been around a base around 1.6 for the last 10 (!!) months. For a 50M market cap company this is absurd, but given how slow management has performed, could be another 10 months between 1.5 and 2

$MDAI Looking through everything from today, I'm really happy with the presentation and direction. The CMS decision in November is fairly important, but I don't see any reason to believe they won't get the band they're asking for. I also like that they touched on the handheld device for hospice/home health along with the intent to expand the label in the next 9 months. Often the best way to attract buyers is to position yourself as if you don't want them.

$MDAI No predicate for their device, continued BARDA support, pending handheld version, subscription based billing, for starters.